Denali Therapeutics Ownership | Who Owns Denali Therapeutics?
Denali Therapeutics Ownership Summary
Denali Therapeutics is owned by 81.37% institutional investors, 4.59% insiders, and 14.04% retail investors. Blackrock is the largest institutional shareholder, holding 8.82% of DNLI shares. Scottish Mortgage Ord is the top mutual fund, with 4.39% of its assets in Denali Therapeutics shares.
DNLI Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Denali Therapeutics | 81.37% | 4.59% | 14.04% |
| Sector | Healthcare Stocks | 128.69% | 12.02% | -40.72% |
| Industry | Biotech Stocks | 180.58% | 11.62% | -92.20% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Blackrock | 13.17M | 8.82% | $305.91M |
| T. rowe price investment management | 16.18M | 8.67% | $416.12M |
| Blackrock funding, inc. /de | 14.33M | 7.65% | $296.17M |
| Vanguard group | 13.06M | 7.57% | $215.59M |
| Baillie gifford | 11.12M | 5.94% | $229.85M |
| Temasek (private) | 7.01M | 3.74% | $144.96M |
| Vanguard portfolio management | 6.76M | 3.61% | $139.70M |
| Vanguard capital management | 6.75M | 3.60% | $139.55M |
| State street | 6.68M | 3.57% | $138.12M |
| Fmr | 4.53M | 2.42% | $93.70M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Crestline management, lp | 1.91M | 91.90% | $49.14M |
| Foresite capital management vi | 1.40M | 5.59% | $35.92M |
| Dafna capital management | 739.01K | 3.62% | $19.01M |
| Casdin capital | 2.04M | 2.63% | $52.60M |
| Prosight management, lp | 550.70K | 2.21% | $11.38M |
| Cercano management | 625.00K | 1.77% | $12.92M |
| Adar1 capital management | 1.03M | 1.21% | $26.47M |
| Boxer capital management | 250.00K | 1.16% | $3.63M |
| Yiheng capital management | 469.98K | 1.01% | $6.82M |
| Privium fund management b.v. | 229.86K | 0.92% | $4.75M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| T. rowe price investment management | 16.18M | 0.27% | 7.66M |
| Norges bank | 2.82M | 0.01% | 2.82M |
| Macquarie management | 2.21M | 0.09% | 2.09M |
| Vanguard group | 13.06M | 0.00% | 1.06M |
| Blackrock | 13.17M | 0.01% | 974.71K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Lynx1 capital management lp | 11.66K | 0.06% | -1.87M |
| Vestal point capital, lp | - | - | -1.77M |
| Alyeska investment group | 219.33K | 0.01% | -1.72M |
| Point72 asset management | - | - | -1.70M |
| Flagship pioneering | - | - | -1.36M |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Norges bank | 2.82M | 0.01% | 2.82M | $72.65M |
| Prosight management, lp | 550.70K | 2.21% | 550.70K | $11.38M |
| Campbell & co investment adviser | 366.60K | 0.32% | 366.60K | $7.58M |
| Axa investment managers | 294.73K | 0.01% | 294.73K | $4.28M |
| Schonfeld strategic advisors | 226.20K | 0.02% | 226.20K | $3.28M |
Sold Out
| Holder | Change |
|---|---|
| Truvestments capital | -1.00 |
| Vermillion wealth management | -1.00 |
| Curio wealth | -1.00 |
| Toronto dominion bank | -2.00 |
| Jpl wealth management | -2.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2026 | 294 | -2.97% | 152,418,519 | -3.21% | 81 | 1.15% | 140 | -21.79% | 87 | 26.09% |
| Jun 30, 2026 | 298 | 5.67% | 157,296,914 | 6.71% | 84 | 1.19% | 179 | 11.18% | 66 | 11.86% |
| Mar 31, 2026 | 235 | -7.11% | 121,971,228 | -19.30% | 69 | 0.90% | 136 | - | 47 | -33.80% |
| Dec 31, 2025 | 69 | -71.60% | 34,419,053 | -74.60% | 19 | 0.32% | 37 | -70.63% | 15 | -76.92% |
| Sep 30, 2025 | 84 | -62.83% | 32,008,693 | -75.36% | 18 | 0.33% | 39 | -67.77% | 28 | -56.25% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Scottish Mortgage Ord | 7.04M | 4.39% | - |
| T. Rowe Price Capital Appreciation | 6.55M | 4.10% | - |
| Vanguard Health Care Inv | 4.40M | 3.03% | -5.17M |
| Vanguard MStar Total Stk Mkt Idx Invest | 4.68M | 2.93% | 377.96K |
| Vanguard Morn Total Stk Mkt Idx Investor | 4.29M | 2.70% | 20.55K |
| Vanguard Total Stock Mkt Idx Inv | 4.29M | 2.70% | 20.55K |
| iShares Russell 2000 ETF | 3.74M | 2.33% | - |
| Vanguard US Total Market Shares ETF | 3.33M | 2.29% | -161.11K |
| State Street® SPDR® S&P® Biotech ETF | 3.28M | 2.05% | 85.78K |
| Vanguard Small Cap Index | 3.24M | 2.03% | 137.87K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Sep 04, 2026 | Chin Peter Scott | Chief Medical Officer | Sell | $36.87K |
| Sep 02, 2026 | Thornberry Nancy | - | Sell | $14.60K |
| Sep 02, 2026 | Thornberry Nancy | - | Sell | $247.33K |
| Sep 01, 2026 | Schuth Alexander O. | COFO and Secretary | Sell | $64.88K |
| Aug 11, 2026 | Schuth Alexander O. | COFO and Secretary | Sell | $71.62K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2026 Q4 | - | - |
| 2026 Q3 | - | 5 |
| 2026 Q2 | - | - |
| 2026 Q1 | - | 2 |
| 2025 Q4 | 2 | - |
DNLI Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools